Flow-Through Cell Method and IVIVR for Poorly Soluble Drugs

被引:0
作者
Waehling, Catharina [1 ]
Schroeter, Christian [1 ]
Hanefeld, Andrea [1 ]
机构
[1] Merck KGaA, CMC Dev, D-64291 Darmstadt, Germany
来源
DISSOLUTION TECHNOLOGIES | 2011年 / 18卷 / 04期
关键词
BILE-SALT SOLUTIONS; INVITRO DISSOLUTION; GLUTETHIMIDE GRISEOFULVIN; SOLUBILIZING PROPERTIES; RELEASE; ABSORPTION; MEDIA;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The percentage of poorly soluble compounds in drug discovery and development increases steadily. A variety of possibilities exists for increasing solubility and bioavailability; among them is the formation of salts. For the characterization of poorly soluble active pharmaceutical ingredients (API), it is necessary to develop appropriate analytical methods to determine relevant physicochemical properties. One important physicochemical parameter is the dissolution rate. As the flow-through cell (FTC) offers various advantages, such as operating with pH gradients and in sink conditions or applying unlimited amount of media,the FTC is particularly suitable for poorly soluble compounds. When developing an FTC method it is important to consider the physiological circumstances. By choosing the appropriate conditions for media, volume, flow rate, and so forth, it is possible to predict in vivo behavior. The focus of this work was to develop a small-scale FTC method for poorly soluble compounds designed for determining dissolution kinetics in the early development phase, where only limited amount of drug is available. The predictive power of the presented system could be demonstrated by an in vitro in vivo relationship (IVIVR) study.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 56 条
[41]  
Rohrs BR, 2001, DISSOLUT TECHNOL, V8, P1
[42]   Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs [J].
Serajuddin, ATM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (10) :1058-1066
[43]   IN-VITRO DISSOLUTION OF SPARINGLY WATER-SOLUBLE DRUG-DOSAGE FORMS [J].
SHAH, VP ;
NOORY, A ;
NOORY, C ;
MCCULLOUGH, B ;
CLARKE, S ;
EVERETT, R ;
NAVIASKY, H ;
SRINIVASAN, BN ;
FORTMAN, D ;
SKELLY, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (01) :99-106
[44]   INVITRO DISSOLUTION PROFILE OF WATER-INSOLUBLE DRUG-DOSAGE FORMS IN THE PRESENCE OF SURFACTANTS [J].
SHAH, VP ;
KONECNY, JJ ;
EVERETT, RL ;
MCCULLOUGH, B ;
NOORIZADEH, AC ;
SKELLY, JP .
PHARMACEUTICAL RESEARCH, 1989, 6 (07) :612-618
[45]   MECHANISTIC STUDY OF INFLUENCE OF MICELLE SOLUBILIZATION AND HYDRODYNAMIC FACTORS ON DISSOLUTION RATE OF SOLID DRUGS [J].
SINGH, P ;
DESAI, SJ ;
FLANAGAN, DR ;
SIMONELL.AP ;
HIGUCHI, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (06) :959-&
[46]   When poor solubility becomes an issue:: From early stage to proof of concept [J].
Stegemann, S. ;
Leveiller, F. ;
Franchi, D. ;
de Jong, H. ;
Linden, H. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 31 (05) :249-261
[47]  
Stippler E., 2004, Dissolution Technol, V11, P6, DOI [10.14227/DT110204P6, DOI 10.14227/DT110204P6]
[48]   In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media [J].
Sunesen, VH ;
Pedersen, BL ;
Kristensen, HG ;
Müllertz, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (04) :305-313
[49]  
*US FDA, 2000, WAIV IN VIV BIOAV BI
[50]   Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds [J].
Vertzoni, M ;
Dressman, J ;
Butler, J ;
Hempenstall, J ;
Reppas, C .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (03) :413-417